In human colon cancer cells, inhibition of aldose reductase significantly increased PTEN and FOXO3a expression via the growth factor-induced ROS/PI3K/AKT axis, thereby downregulating miR-21 expression and inhibiting colon cancer growth [82]. Here, AKT1 is linked to malignant colon neoplasm.